申请人:Medicinal Bioconvergence Research Center
公开号:EP3939968A1
公开(公告)日:2022-01-19
The present invention pertains to a novel compound having anticancer activity, and a method for producing same, and more specifically, to a novel compound that exhibits excellent anticancer activity by inhibiting the expression of AIMP2-DX2, and a method for producing same. The compound represented by chemical formula 1 according to the present invention is highly effective in inhibiting the expression of AIMP2-DX2, and thus can be very advantageously used for the development of agents for treating various diseases, in particular cancer, caused by AIMP2-DX2.
本发明涉及一种具有抗癌活性的新型化合物及其生产方法,更具体地说,涉及一种通过抑制 AIMP2-DX2 的表达而表现出优异抗癌活性的新型化合物及其生产方法。根据本发明的化学式 1 所代表的化合物在抑制 AIMP2-DX2 的表达方面非常有效,因此可以非常有利地用于开发治疗由 AIMP2-DX2 引起的各种疾病,特别是癌症的药物。